Overall survival of patients with chemotherapy-naive advanced melanoma treated with ipilimumab 3 mg/kg in clinical trials

相似書籍

• Overall survival at 5 years of follow-up in a phase III trial comparing ipilimumab 10 mg/kg with 3 mg/kg in patients with advanced melanoma
  由: Ascierto, Paolo Antonio, et al.
  出版: (2020)
• Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
  由: Wolchok, J.D., et al.
  出版: (2017)
• Correction: Overall survival at 5 years of follow-up in a phase III trial comparing ipilimumab 10 mg/kg with 3 mg/kg in patients with advanced melanoma
  出版: (2020)
• A randomized controlled comparison of pembrolizumab and chemotherapy in patients with ipilimumab-refractory melanoma
  由: Dummer, Reinhard, et al.
  出版: (2015)
• Efficacy of radiotherapy in patients on progression after treatment with ipilimumab 3 mg/kg
  由: Grimaldi, Antonio M, et al.
  出版: (2014)